Breaking News, Promotions & Moves

Mytide Names Martina Diekmann CEO

Will help company transition from technology development into production and revenue growth.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mytide, a tech-enabled biotechnology manufacturing services company, appointed Martina Diekmann CEO. She will take over as CEO from Mytide’s founder Dale Thomas, who has been CEO since 2018. Following Diekmann’s appointment, Thomas will assume the role of chief technology officer with a focus on driving future innovation. According to the company, Thomas has been instrumental in establishing Mytide, known for its innovative automated peptide manufacturing platform that combines machine lea...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters